CANF (Can-Fite BioPharma) Wutah bathi resik saben saham ing taun iki

CANF (Can-Fite) - tandha merek perusahaan

Demand for cutting-edge oncology developments is sustained by the synergy of elite scientists and generous funding. The annual relative change in EPS illustrates the current price action of Can-Fite BioPharma (CANF), where 65.30 reflects the latest value of the metric. Business efficiency is based on robotic compound bioscreening and the imminent commercial market launch of drugs for the treatment of psoriasis and liver disease.

Wutah bathi saben saham ing taun lumaku: Can-Fite BioPharma Ltd (CANF) kanggo 04.07.2022 - 11.11.2026

Rincian metrik keuangan lan pasar Can-Fite BioPharma (CANF)

- kuotasi lan prakiraan analis:
Kurs saham Can-Fite BioPharma Ltd|CANF - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar Can-Fite|CANF - Nilai Total Perusahaan
- rincian nilai buku perusahaan:
Nilai Aset Bersih saben Saham Can-Fite BioPharma|CANF - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku canfite.com|CANF - Aset Agregat Perusahaan
- rincian utang lan likuiditas:
Utang marang Modal Can-Fite BioPharma|CANF - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas canfite.com|CANF - Gunggung utang perusahaan|Utang-utang marang nilai buku Can-Fite|CANF - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Can-Fite BioPharma|Rasio likuiditas perantara canfite.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CANF - Bathi resik|Penghasilan resik sing dikarepake Can-Fite BioPharma|CANF - Pangali P/E|Rasio prakiraan rega marang bathi Can-Fite|CANF - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Can-Fite|CANF - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Can-Fite BioPharma|CANF - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan canfite.com|CANF - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun ngarep Can-Fite BioPharma
Ringkesan analisis perusahaan:CANF Can-Fite BioPharma Ltd
Produk mawa merek Can-Fite BioPharma

This indicator measures earnings per share (EPS) dynamics, determining the pace of business scaling relative to the previous year. For Can-Fite BioPharma (CANF), this calculation is critical, as high oncology development costs create negative leverage. By analyzing annual EPS progress, an investor can see the impact of future licensing payments on the bottom line. A positive trend confirms the effectiveness of drug commercialization, while slowing growth signals a risk of capital freeze.

Pesaing wigati

Wutah bathi saben saham ing taun iki INCY|HCM (HUTCHMED Ltd) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Nuvation Corp (NUVB)|Wutah bathi saben saham ing taun lumaku Day One (DAWN)|MNPR - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Inhibrx Biosciences, Inc. INBX|I-Mab Biopharma Co., Ltd. - Wutah bathi saben saham ing taun lumaku|FENC - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Heron Therapeutics|NVCT: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Coherus BioSciences CHRS|Wutah bathi resik saben saham ing taun iki CRBP|Kacepetan wutah bathi saben saham ing taun lumaku Cardiff Oncology Corp CRDF|Wutah bathi resik saben saham ing taun iki BYSI (BeyondSpring Pharma)|BCAB (bioatla.com) - Tambahing bathi saben saham ing taun lumaku|Lixte Biotechnology - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CTXR (Citius Pharmaceuticals Inc.)|Cellectar Biosciences, Inc. - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku BLRX (BioLineRx Ltd)|APRE: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Kazia Therapeutics Limited (KZIA)|Wutah bathi saben saham ing taun lumaku Silexion Therapeutics Corp.|NCNA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CMRX|Wutah bathi ing taun lumaku Cyclacel Pharmaceuticals, Inc. (CYCC)|Wutah bathi saben saham ing taun lumaku G1 Therapeutics GTHX|KRON (Kronos Bio Corporation) - Dinamika bathi saben saham ing taun lumaku|KTRA: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku oncternal.com|PRTG: Wutah bathi ing taun lumaku